Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
EB

Eric Benjamin — 17 Patents

Pfizer: 7 patents #741 of 5,153Top 15%
S(Syntex (U.S.A.): 3 patents #196 of 599Top 35%
INInsulet: 3 patents #34 of 127Top 30%
PHPharmacia: 1 patents #1,295 of 1,582Top 85%
TPTranstech Pharma: 1 patents #53 of 65Top 85%
VTVtv Therapeutics: 1 patents #31 of 50Top 65%
Cambridge, MA: #614 of 8,183 inventorsTop 8%
Massachusetts: #7,047 of 88,656 inventorsTop 8%
Overall (All Time): #263,971 of 4,157,543Top 7%
17 Patents All Time
Eric Benjamin has been granted 17 US patents while listed as an inventor at Pfizer. The first was granted in 1983 and the most recent in September 2025. Eric Benjamin ranks #263,971 of 4,157,543 US inventors in our database (top 6.3%). Patent records list Eric Benjamin in Cambridge, MA, US.

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12431229 Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions Joon Bok LEE, Jason O'CONNOR, Yibin ZHENG 2025-09-30
11957875 Techniques and devices providing adaptivity and personalization in diabetes treatment Yibin ZHENG, Joon Bok LEE, Steven P. Cardinali, Jason O'CONNOR, Ian McLaughlin +2 more 2024-04-16 $55,373,000
11935637 Onboarding and total daily insulin adaptivity Joon Bok LEE, Yibin ZHENG, Jason O'CONNOR, Trang LY 2024-03-19 $107,133,000
11179369 Sustained release pharmaceutical compositions Wendy Ann Dulin, Yanning Lin, Kai Zhuang 2021-11-23
10463648 Sustained release pharmaceutical compositions Wendy Ann Dulin, Yanning Lin, Kai Zhuang 2019-11-05
10292966 Sustained release pharmaceutical compositions Wendy Ann Dulin, Yanning Lin, Kai Zhuang 2019-05-21
9198901 Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and pharmaceutical compositions and uses thereof Danilo Almariego, Dharma Rao Polisetti, Hassan El Abdellaoui, Soumya P. Sahoo 2015-12-01 $1,290,000
7981424 RAGE fusion proteins, formulations, and methods of use thereof Adnan M. M. Mjalli, Robert Rothlein, Ye Tian, Jeffrey C. Webster 2011-07-19
7759386 Pharmaceutical compositions of estrogenic agents Wendy Ann Dulin, Jiwaji Gulabrao Suryawanshi 2010-07-20
7446111 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions Muhammad Ashraf, Ashwinkumar Jain 2008-11-04 $59,766,000
7271177 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions Muhammad Ashraf, Ashwinkumar Jain 2007-09-18 $47,662,000
6815424 Intranasal administration of polypeptides in powdered form Brian H. Vickery, Cherng-Chyi Fu, Lynda M. Sanders 2004-11-09 $245,520,000
6521597 Intranasal administration of LHRH polypeptides in powdered form Brian H. Vickery, Cherng-Chyi Fu, Lynda M. Sanders 2003-02-18 $132,481,000
4983595 Aqueous steroid formulations for nasal administration Shabbir T. Anik, Ya-Yun T. Lin 1991-01-08 $14,732,000
4837239 Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins Gary Conard Visor 1989-06-06 $20,803,000
4782047 Aqueous steroid formulations for nasal administration Shabbir T. Anik, Ya-Yun T. Lin 1988-11-01 $16,066,000
4382091 Stabilization of 1-substituted imidazole derivatives in talc Maryann O. Lee, Lih-Yang Lin 1983-05-03 $14,111,000